Cancer News and Research

Latest Cancer News and Research

20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors

20/20 GeneSystems, Inc. announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.

15 Sep 2010

Methodist surgeons perform multiple cardiac vessel bypasses through small single incision

Surgeons at the Methodist DeBakey Heart & Vascular Center perform multiple cardiac vessel bypasses through a single, small incision in the patient's side, reducing pain, recovery time and risk for infection.

15 Sep 2010

Researchers create artificial human ovary to yield infertility treatments for cancer patients

Researchers at Brown University and Women & Infants Hospital have invented the first artificial human ovary, an advance that provides a potentially powerful new means for conducting fertility research and could also yield infertility treatments for cancer patients. The team has already used the lab-grown organ to mature human eggs.

15 Sep 2010

Canadian Cancer Society, POGO collaborate to improve quality of life in childhood cancer survivors

The Canadian Cancer Society and the Pediatric Oncology Group of Ontario (POGO) today announced that they have joined forces to improve the quality of outcomes for children and adolescents diagnosed with cancer and their families.

15 Sep 2010

microRNA 451 enhances treatment response in stomach cancer patients: Research

"The high presence of microRNA 451 enhances the response to treatment with chemo-radiotherapy and increases the survival of patients with stomach cancer", explained Dr. Jesús García-Foncillas, chief researcher of the Pharmacogenomics Laboratory at the Applied Medical Research Centre (CIMA) and Director of Oncology at the University Hospital of Navarra. This was one of the results presented at the IV Congress of the Spanish Society for Pharmacogenetics and Pharmacogenomic, recently held at CIMA.

15 Sep 2010

Researchers identify risk gene for schizophrenia

An international team of researchers has identified a risk gene for schizophrenia, including a potentially causative mutation, using genome-wide association data-mining techniques and independent replications.

15 Sep 2010

Helix BioPharma receives authorization to list shares on NYSE Amex stock exchange

Helix BioPharma Corp. today announced that it has been authorized to list its shares of common stock on the NYSE Amex stock exchange. The Company expects that shares of its common stock will begin trading on the NYSE Amex on September 15, 2010, under the trading symbol "HBP."

15 Sep 2010

Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.

15 Sep 2010

Researchers develop new blood test to predict prostate cancer risk

A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden. The findings, published today online in the British Medical Journal, could have important implications for determining which men should be screened after the age of 60 and which may not benefit substantially from continued prostate cancer screening.

15 Sep 2010

Researchers unveil watercress compound can block pathway for cancer development

The research, unveiled at a press conference today (14 September 2010), shows that the watercress compound is able to interfere with the function of a protein which plays a critical role in cancer development.

15 Sep 2010

Scientists discover study of calcium deposits helps effective breast cancer diagnosis

SCIENTISTS have discovered for the first time that studying calcium deposits in the breast, often detected through screening, could help doctors diagnose breast cancer more effectively.The study, published in the British Journal of Cancer today (Wednesday), examined the relationship between the composition of these deposits found in breast tissue and the malignancy of a tumour.

15 Sep 2010

Apricus Biosciences announces reformulation of Rituxan enables rectal delivery of biologics

Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.

15 Sep 2010

Jim Stynes battle with cancer documentary to inspire people

Jim Stynes, the former AFL football star said he was motivated to participate in a documentary about his life and his battle with cancer to inspire people. The 1991 AFL Brownlow Medallist and current chairman of Melbourne Football Club is more than a year into his battle with cancer.

14 Sep 2010

Professor Nygren reviews current state of IVF safety

Now a review by the Chair of the international body which collects data on IVF concludes that IVF is generally safe, although he stresses that patients need to be made aware of the slight risks, and that we need to continue to monitor the results of the technique.

14 Sep 2010

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

The recent news that Michael Douglas has been diagnosed with stage 4 throat cancer has raised public awareness of head and neck cancer. What causes throat cancer and what are the symptoms? Are there ways to prevent or reduce the risk of throat cancer? How is the human papillomavirus (HPV) related to oral cancer?

14 Sep 2010

Target shoppers can help St. Jude's in fight against cancer, catastrophic diseases

Many of the public's favorite household brands have joined forces to support the lifesaving work of St. Jude Children's Research Hospital, one of the world's premier pediatric cancer research centers. From September 19 - 25, Target guests can help St. Jude in its fight to find cures and save children with cancer and other catastrophic diseases by purchasing participating Procter & Gamble (P&G) brands including Tide, Charmin, Bounty and Pampers as well as other manufacturers' brands at Target stores nationwide.

14 Sep 2010

TeleHealth Services announces new partnership with TRHMC to improve patient experience

TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center. The 671-bed hospital chose TeleHealth Services as their interactive patient education and entertainment partner as an extension of the hospital's Surgical Care Improvement Project.

14 Sep 2010

CSC launches new educational program to enhance lymphoma patient, physician communication

The Cancer Support Community (CSC), uniting The Wellness Community and Gilda's Club Worldwide, announced today the launch of Framing Life With Lymphoma, a new educational program designed to enhance lymphoma patient and physician communication.

14 Sep 2010

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

TenX Biopharma, Inc. announced today that data from a Phase II trial of zanolimumab (HuMax-CD4®) in peripheral T-cell Lymphoma were published in the British Journal of Haematology (Sep 2010: 150(5):565-73). The Hx-CD4-109 trial was designed to evaluate the safety and efficacy of zanolimumab in patients who have relapsed or refractory non-cutaneous peripheral T-cell lymphoma.

14 Sep 2010

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Gentium S.p.A. today announced that two posters and one oral presentation on defibrotide will be presented at the 33rd World Congress of International Society of Hematology to be held at the ICC Jerusalem International Convention Center in Jerusalem, Israel, October 10-13, 2010.

14 Sep 2010

Cancer News and Research

Latest Cancer News and Research

20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors

Methodist surgeons perform multiple cardiac vessel bypasses through small single incision

Researchers create artificial human ovary to yield infertility treatments for cancer patients

Canadian Cancer Society, POGO collaborate to improve quality of life in childhood cancer survivors

microRNA 451 enhances treatment response in stomach cancer patients: Research

Researchers identify risk gene for schizophrenia

Helix BioPharma receives authorization to list shares on NYSE Amex stock exchange

Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer

Researchers develop new blood test to predict prostate cancer risk

Researchers unveil watercress compound can block pathway for cancer development

Scientists discover study of calcium deposits helps effective breast cancer diagnosis

Apricus Biosciences announces reformulation of Rituxan enables rectal delivery of biologics

Jim Stynes battle with cancer documentary to inspire people

Professor Nygren reviews current state of IVF safety

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

Target shoppers can help St. Jude's in fight against cancer, catastrophic diseases

TeleHealth Services announces new partnership with TRHMC to improve patient experience

CSC launches new educational program to enhance lymphoma patient, physician communication

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in